Characterizing SARS-CoV-2 viral clearance kinetics to improve the design of antiviral pharmacometric studies by Watson, JA, Kissler, SM, Day, NPJ, Grad, YH, White, NJ

Infectious disease surveillance needs for the United States: lessons from Covid-19 by Lipsitch, M, Bassett, MT, Brownstein, JS, Elliott, P, Eyre, D, Grabowski, MK, Hay, JA, Johansson, MA, Kissler, SM, Larremore, DB, Layden, JE, Lessler, J, Lynfield, R, MacCannell, D, Madoff, LC, Metcalf, CJE, Meyers, LA, Ofori, SK, Quinn, C, Bento, AI, Reich, NG, Riley, S, Rosenfeld, R, Samore, MH